Literature DB >> 22633542

The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.

A Sahgal1, D Roberge, D Schellenberg, T G Purdie, A Swaminath, J Pantarotto, E Filion, Z Gabos, J Butler, D Letourneau, G L Masucci, L Mulroy, A Bezjak, L A Dawson, M Parliament.   

Abstract

AIMS: The Canadian Association of Radiation Oncology-Stereotactic Body Radiotherapy (CARO-SBRT) Task Force was established in 2010. The aim was to define the scope of practice guidelines for the profession to ensure safe practice specific for the most common sites of lung, liver and spine SBRT.
MATERIALS AND METHODS: A group of Canadian SBRT experts were charged by our national radiation oncology organisation (CARO) to define the basic principles and technologies for SBRT practice, to propose the minimum technological requirements for safe practice with a focus on simulation and image guidance and to outline procedural considerations for radiation oncology departments to consider when establishing an SBRT programme.
RESULTS: We recognised that SBRT should be considered as a specific programme within a radiation department, and we provide a definition of SBRT according to a Canadian consensus. We outlined the basic requirements for safe simulation as they pertain to spine, lung and liver tumours, and the fundamentals of image guidance. The roles of the radiation oncologist, medical physicist and dosimetrist have been detailed such that we strongly recommend the development of SBRT-specific teams. Quality assurance is a key programmatic aspect for safe SBRT practice, and we outline the basic principles of appropriate quality assurance specific to SBRT.
CONCLUSION: This CARO scope of practice guideline for SBRT is specific to liver, lung and spine tumours. The task force recommendations are designed to assist departments in establishing safe and robust SBRT programmes.
Copyright © 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22633542     DOI: 10.1016/j.clon.2012.04.006

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  58 in total

1.  Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.

Authors:  Sun Hyun Bae; Mi-Sook Kim; Won Il Jang; Chul-Seung Kay; Woochul Kim; Eun Seog Kim; Jin Ho Kim; Jin Hee Kim; Kwang Mo Yang; Kyu Chan Lee; A Ram Chang; Sunmi Jo
Journal:  Jpn J Clin Oncol       Date:  2016-01-29       Impact factor: 3.019

Review 2.  Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions.

Authors:  Anand Swaminath; William Chu
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

3.  Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis.

Authors:  Ori Barzilai; Natalie DiStefano; Eric Lis; Yoshiya Yamada; D Michael Lovelock; Andrew N Fontanella; Mark H Bilsky; Ilya Laufer
Journal:  J Neurosurg Spine       Date:  2017-11-03

Review 4.  The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer.

Authors:  Jim N Rose; Juanita M Crook
Journal:  Ther Adv Urol       Date:  2015-06

5.  A comparison of stereotactic body radiation therapy for metastases to the sacral spine and treatment of the thoracolumbar spine.

Authors:  Roman O Kowalchuk; Michael R Waters; K Martin Richardson; Kelly Spencer; James M Larner; Jason P Sheehan; William H McAllister; Charles R Kersh
Journal:  J Radiosurg SBRT       Date:  2020

6.  Modern approaches to the management of metastatic epidural spinal cord compression.

Authors:  Zain A Husain; Arjun Sahgal; Eric L Chang; Pejman Jabehdar Maralani; Charlotte D Kubicky; Kristin J Redmond; Charles Fisher; Ilya Laufer; Simon S Lo
Journal:  CNS Oncol       Date:  2017-07-18

7.  Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease.

Authors:  J A Broomfield; J N Greenspoon; A Swaminath
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

8.  Interview: Current state of brain and spine radiosurgery and future applications.

Authors:  Arjun Sahgal
Journal:  CNS Oncol       Date:  2013-01

9.  Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study.

Authors:  Luluel Khan; Andrew Chiang; Liying Zhang; Isabelle Thibault; Gillian Bedard; Erin Wong; Andrew Loblaw; Hany Soliman; Michael G Fehlings; Edward Chow; Arjun Sahgal
Journal:  Support Care Cancer       Date:  2015-03-10       Impact factor: 3.603

Review 10.  Treatment of metastatic liver tumors using stereotactic ablative radiotherapy.

Authors:  Vimoj J Nair; Jason R Pantarotto
Journal:  World J Radiol       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.